Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Glimepiride (4mg) Tablet
Dosage Form : Tablet
Packaging Type : Blister
Packaging : 10*10
Price : ₹0/-
Glibclay 4 Tablet contains Glimepiride 4mg, a potent sulfonylurea that helps improve glycemic control in patients with type-2 diabetes mellitus. It effectively stimulates pancreatic insulin secretion and assists in maintaining blood glucose levels within the desired range.
Glimepiride enhances the body's insulin response to elevated blood sugar, providing regulation of both fasting and postprandial glucose levels. Its once-daily oral administration ensures convenience and promotes patient compliance in long-term diabetes management.
This tablet is suitable for patients inadequately controlled by diet, exercise, or monotherapy, offering proven efficacy with a safe and tolerable profile. It is widely used in both outpatient and hospital-based diabetes care.
Adding Glibclay 4 Tablet to your diabetes and metabolic-care portfolio expands your product range, providing opportunities in retail pharmacy distribution, hospital procurement, institutional orders, export channels, and third-party manufacturing. Its high prescription demand guarantees steady commercial performance.
Some patients may experience hypoglycemia, dizziness, nausea, or mild gastrointestinal discomfort. Rarely, weight gain, allergic reactions, or hematologic abnormalities may occur.
Glibclay 4 Tablet is indicated for the management of type 2 diabetes mellitus in patients who require medication in addition to diet and exercise for effective glycemic control. It helps reduce both fasting and postprandial blood sugar levels.
Use strictly under medical supervision. Regular monitoring of blood glucose is recommended to prevent hypoglycemia. Avoid use in patients with severe renal or hepatic impairment. Follow the prescribed dosage and lifestyle guidance carefully.
Store in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.
Composition : Calcium Dobesilate Monohydrate I.P. 500 mg Capsule
Composition : L-Arginine (3gm) + Proanthocyanidin (75mg) sachet
Composition : Aminacrine HCl 0.1g + Cetrimide Cream 0.5g
Composition : Chlorhexidine Gluconate (0.20% w/w) + Silver Nitrate (0.20% w/w) cream
Composition : Hydroquinone (2% w/w) + Mometasone (0.1% w/w) + Tretinoin (0.025% w/w)
Composition : Fusidic Acid I.P. 2.00% w/w + Beclomethasone Dipropionate I.P. 0.025% w/w
Composition : Cranberry Extract 300mg + D-Mannose 600mg Tablet
Composition : Ketoconazole (2.0% w/w) + Clobetasol Propionate (0.05% w/w) + Neomycin (0.10% w/w) + Tolnaflate (1.0% w/w) + Iodochlorhydroxy Quinoline (1.0% w/w) Cream
Composition : Terbinafine (1% w/w)
Composition : Tretinoin 0.05% Cream
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation